Aliment Pharmacol Ther
- TRUNIGER S, Waber D, Dutschler J, Konig M, et al
Anti-Integrin alphavbeta6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's
Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A
Prospective Cross-Sectional Study.
Aliment Pharmacol Ther. 2026 Aug 20. doi: 10.1111/apt.70926.
BMC Gastroenterol
- CHUAI Q, Jiang X, Li K, Liu X, et al
Identification of IL1RN, MUC1, and SERPINA1 as key NET-related biomarkers in
ulcerative colitis-associated intestinal fibrosis via bioinformatics and
experimental validation.
BMC Gastroenterol. 2026;26:513.
- GERBIER E, Abolhassani N, Dupuis M, Oppliger B, et al
Use of medications to treat inflammatory bowel diseases before and during
pregnancy in Switzerland between 2012 and 2019: an observational study using the
claims-based MAMA cohort.
BMC Gastroenterol. 2026;26:511.
Clin Gastroenterol Hepatol
- PATEL PV, Moses J, Ali S, Suskind DL, et al
Aminosalicylate use Increases Corticosteroid Exposure and Decreases Biologic
Durability in Pediatric Crohn's Disease.
Clin Gastroenterol Hepatol. 2026 Aug 21:S1542-3565(26)00630.
Clin Res Hepatol Gastroenterol
- NIKAM PP
Beyond Risk Stratification: Can the Crohn's Disease Clinical Decision Support
Tool Truly Guide Resource Allocation?
Clin Res Hepatol Gastroenterol. 2026 Aug 18:102907.
Dig Dis
- KHASAWNEH O, Gerges KM, Khasawneh I, Savarino EV, et al
Using GLP-1 Receptor Agonists in Patients with Inflammatory Bowel Disease: A
Systematic Review and Single-Arm Meta-Analysis.
Dig Dis. 2026 Aug 18:1-24. doi: 10.1159/000553479.
Dig Dis Sci
- HUSAIN KH, Khan H, Thakkar B, Bungish M, et al
Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human
Evidence, and a Clinical Implementation Framework.
Dig Dis Sci. 2026 Aug 18. doi: 10.1007/s10620-026-10196.
- LETO AC, Shen M, Aberra FN
Homemade Microbrew: Auto-brewery Syndrome in a Patient with Crohn's Disease.
Dig Dis Sci. 2026 Aug 19. doi: 10.1007/s10620-026-10175.
Gastroenterol Hepatol
- LOZANO OM, Camunas AF, Tercero MA, Ramos MJC, et al
Accuracy of the vedolizumab Clinical Decision Support Tool in Crohn's disease and
its association with long-term persistence: A retrospective cohort study.
Gastroenterol Hepatol. 2026 Aug 18:502842. doi: 10.1016/j.gastrohep.2026.502842.
Gastroenterology
- BUCK A, Writz C, Umbach M, Widemann K, et al
WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and
Rho/ROCK/MRTF-mediated cytoskeletal Remodeling.
Gastroenterology. 2026 Aug 18:S0016-5085(26)07150.
- NOBLE A, Antunes C, Ramsteijn AS, Li X, et al
Specific epigenetic alterations precede the diagnosis of Inflammatory Bowel
Disease in adults in Northern Europe: nationwide analysis in Generation Scotland.
Gastroenterology. 2026 Aug 17:S0016-5085(26)07159.
Inflamm Bowel Dis
- ALQINAI B, Gayam S, Hadam-Veverka J
GLP-1 receptor agonist therapy is associated with increased symptomatic remission
in ulcerative colitis: a matched cohort study.
Inflamm Bowel Dis. 2026 Aug 21:izag167. doi: 10.1093.
- BEN-DAVID-NAIM M, Bijaoui D, Iluz N, Adams J, et al
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A
inhibitor.
Inflamm Bowel Dis. 2026 Aug 21:izag170. doi: 10.1093.
- LIU Z, Wu X, Huang W, He J, et al
Novel proteomic signatures of stricturing Crohn disease using a treatment-naive
cohort.
Inflamm Bowel Dis. 2026 Aug 20:izag160. doi: 10.1093.
- JAMAL F, Gonzalez AJ, Thomas G, Viggiano T, et al
Coccidioidomycosis in patients with inflammatory bowel disease receiving advanced
therapy: An observational study from an endemic tertiary center.
Inflamm Bowel Dis. 2026 Aug 19:izag168. doi: 10.1093.
- GROS B, Frutos C, Brunet E, Valentin-Aragon L, et al
Hormonal contraception is not associated with recurrent flares in ulcerative
colitis: a longitudinal time-dependent analysis.
Inflamm Bowel Dis. 2026 Aug 18:izag163. doi: 10.1093.
- LIN SH, Kuo CJ, Chuang CH, Chang CW, et al
Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel
Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST
Study).
Inflamm Bowel Dis. 2026 Aug 18:izag150. doi: 10.1093.
J Crohns Colitis
- SHOUVAL DS, Hojsak I, Miele E, Sokollik C, et al
Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.
J Crohns Colitis. 2026;20:jjag084.
- HAMMOUDA K, Dakarapu R, Rajendra C, Lee H, et al
Automated AI-based Mayo Endoscopic Scoring for ulcerative colitis across adult
and pediatric cohorts from diverse populations.
J Crohns Colitis. 2026;20:jjag122.
- MARTINS M, Nunes MV, Macedo G, Pioche M, et al
Efficacy, safety, and outcomes of endoscopic submucosal dissection for
inflammatory bowel disease-associated colorectal neoplasia: a systematic review
and meta-analysis comparing Asian and Western outcomes.
J Crohns Colitis. 2026;20:jjag082.
J Gastroenterol
- YIN Y, Wang X, Ou D, Zhou Z, et al
Multimodal MRI reveals glymphatic system activity associated with systemic
inflammation and neuropsychiatric symptoms in Crohn's disease.
J Gastroenterol. 2026 Aug 16. doi: 10.1007/s00535-026-02505.
PLoS One
- MUSHTAQ S, Saeed S, Khan A, Akhtar TS, et al
Association between Ulcerative Colitis, mental health, and Quality of Life in a
Pakistani cohort: A cross-sectional analysis.
PLoS One. 2026;21:e0356531.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016